← FDA DRUG APPROVALS

FDA NDA · NDA006325

TUBOCURARINE CHLORIDE

Sponsor: LILLY

APPLICATION
NDA006325
TYPE
NDA
ORIGINAL APPROVAL
1947-11-28
LATEST ACTION
2001-09-17
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

TUBOCURARINE CHLORIDEDiscontinued
TUBOCURARINE CHLORIDE 3MG/ML · INJECTABLE · INJECTION

Approval history

2001-09-17Labeling · Supplement 5AP
2001-09-17Labeling · Supplement 8AP
2001-09-17Labeling · Supplement 12 · standardAP
1993-09-02Labeling · Supplement 9 · standardAP
1987-05-04Labeling · Supplement 7AP
1978-02-16Labeling · Supplement 3AP
1975-03-14Labeling · Supplement 1AP
1947-11-28Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →